Directory
>
Michelle Landolfi
Michelle Landolfi
Vice President, Regulatory Affairs | Protagonist Therapeutics
Menlo Park, California, United States
Michelle Landolfi
Summary
Michelle Landolfi is a seasoned regulatory affairs executive with over 25 years of experience in the biopharmaceutical and biotechnology sectors. Currently serving as the Vice President of Regulatory Affairs at Protagonist Therapeutics, she has a proven track record of successfully guiding drug development processes through complex regulatory landscapes. Her expertise spans clinical development, FDA submissions, and good clinical practices, particularly in the fields of immunology and oncology. Michelle's career has been marked by leadership roles in several reputable organizations, including Corcept Therapeutics and Impax Laboratories. She holds a Ph.D. in Immunology from UT Southwestern Medical Center and a B.S. in Microbiology from the University of Michigan. Known for her strategic vision and collaborative approach, Michelle is passionate about advancing innovative therapies that address unmet medical needs. In addition to her professional achievements, she is committed to mentoring the next generation of leaders in the life sciences industry.
Michelle Landolfi
Work Experience
Vice President, Regulatory Affairs at
Protagonist Therapeutics
November 2020 - Present
Senior Director, Regulatory Affairs at
Corcept Therapeutics
July 2019 - November 2020
Senior Director, Regulatory Affairs at
Impax Laboratories
November 2016 - April 2019
Senior Director, Regulatory Affairs at
Intarcia Therapeutics
April 2016 - November 2016
Associate Director, Regulatory Affairs at
Jnj
October 2006 - June 2008
Research Associate at
Stanford University Medical Center
January 1988 - January 1996
Michelle Landolfi
Education
UT Southwestern Medical Center, Ph.D.
University of Michigan, B.S.
Frequently Asked Questions about Michelle Landolfi
What is Michelle Landolfi email address?
Michelle Landolfi's primary email address is **********@protagonist-inc.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michelle Landolfi work for?
Michelle Landolfi is a Vice President, Regulatory Affairs at Protagonist Therapeutics, a company specializing in Pharmaceutical preparations.
Where Michelle Landolfi graduated from?
Michelle Landolfi holds a degree in Immunology from UT Southwestern Medical Center.
How can I directly contact Michelle Landolfi?
To contact Michelle Landolfi directly, you can use the email address **********@protagonist-inc.com. Complete contact information is available upon registration with Muraena.
Who is Michelle Landolfi?
Michelle Landolfi is a seasoned regulatory affairs executive with over 25 years of experience in the biopharmaceutical and biotechnology sectors. Currently serving as the Vice President of Regulatory Affairs at Protagonist Therapeutics, she has a proven track record of successfully guiding drug development processes through complex regulatory landscapes. Her expertise spans clinical development, FDA submissions, and good clinical practices, particularly in the fields of immunology and oncology. Michelle's career has been marked by leadership roles in several reputable organizations, including Corcept Therapeutics and Impax Laboratories. She holds a Ph.D. in Immunology from UT Southwestern Medical Center and a B.S. in Microbiology from the University of Michigan. Known for her strategic vision and collaborative approach, Michelle is passionate about advancing innovative therapies that address unmet medical needs. In addition to her professional achievements, she is committed to mentoring the next generation of leaders in the life sciences industry.
Michelle`s contact details
**********@protagonist-inc.com
**********@att.net
*****************@intarcia.com
*****************@impaxlabs.com
Colleagues
VP, Medical Affairs
EVP Program and Portfolio Management
Executive Director, Global Regulatory Affairs
Chief Development Officer
EVP & Chief Technical Officer
SVP of Biometrics
Vice President of Biometrics
Adjunct Clinical Professor, Department of Medicine, Division of Oncology
Chief Financial Officer
President & CEO